People: CytRx Corp (CYTR.PH)

CYTR.PH on Philadelphia Stock Exchange

2.21USD
11 Jun 2013
Price Change (% chg)

$0.00 (+0.00%)
Prev Close
$2.21
Open
$2.21
Day's High
$2.21
Day's Low
$2.21
Volume
200
Avg. Vol
--
52-wk High
--
52-wk Low
--

Search Stocks

Rubinfeld, Joseph 

Brief Biography

Dr. Joseph Rubinfeld, Ph.D., is a Independent Director of CytRx Corporation. He co-founded SuperGen, Inc. in 1991 and has served as its Chief Executive Officer and President and as a director since its inception until December 31, 2003. He resigned as Chairman Emeritus of SuperGen, Inc. on February 8, 2005. Dr. Rubinfeld was also Chief Scientific Officer of SuperGen from 1991 until September 1997. Dr. Rubinfeld is also a founder of JJ Pharma. Dr. Rubinfeld was one of the four initial founders of Amgen, Inc. in 1980 and served as a Vice President and its Chief of Operations until 1983. From 1987 until 1990, Dr. Rubinfeld was a Senior Director at Cetus Corporation and from 1968 to 1980, Dr. Rubinfeld was employed at Bristol-Myers Company, International Division in a variety of positions. Dr. Rubinfeld received a B.S. degree in chemistry from C.C.N.Y. and an M.A. and Ph.D. in chemistry from Columbia University.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Max Link

--

Steven Kriegsman

1,518,700

Marvin Selter

--

John Caloz

546,000

Daniel Levitt

786,900

Douglas Wieland

536,000
As Of 30 Dec 2012
Search Stocks